Guideline Concordance of Testing for Hyperkalemia and Kidney Dysfunction During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

Kidney Dysfunction ◽

Antagonist Therapy ◽

Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure

Circulation Cardiovascular Quality and Outcomes ◽

10.1161/circoutcomes.116.002946 ◽

2017 ◽

Vol 10 (1) ◽

Cited By ~ 12

Author(s):

Lauren B. Cooper ◽

Bradley G. Hammill ◽

Eric D. Peterson ◽

Bertram Pitt ◽

Matthew L. Maciejewski ◽

...

Keyword(s):

Heart Failure ◽

High Risk ◽

Receptor Antagonist ◽

Antagonist Therapy ◽

Therapy Initiation ◽

Patients With Heart Failure ◽

Risk Patients

Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

JAMA ◽

10.1001/jama.2015.11904 ◽

2015 ◽

Vol 314 (18) ◽

pp. 1973 ◽

Cited By ~ 40

Author(s):

Lauren B. Cooper ◽

Bradley G. Hammill ◽

Eric D. Peterson ◽

Bertram Pitt ◽

Matthew L. Maciejewski ◽

...

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Laboratory Monitoring ◽

Antagonist Therapy ◽

Laboratory Monitoring after Inpatient and Outpatient Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients with Heart Failure

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2016.06.087 ◽

2016 ◽

Vol 22 (8) ◽

pp. S26

Author(s):

Lauren B. Cooper ◽

Bradley G. Hammill ◽

Eric D. Peterson ◽

Bertram Pitt ◽

Matthew L. Maciejewski ◽

...

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Laboratory Monitoring ◽

Antagonist Therapy ◽

Epithelial Sodium Channel Genotype Is Associated with Elevated Potassium among Patients with Heart Failure Taking a Mineralocorticoid Receptor Antagonist

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2013.06.185 ◽

2013 ◽

Vol 19 (8) ◽

pp. S56

Author(s):

Alexandra Goncharenko ◽

Andrew Kadlec ◽

Adam Bress ◽

Shitalben Patel ◽

Orly Vardeny ◽

...

Keyword(s):

Heart Failure ◽

Sodium Channel ◽

Receptor Antagonist ◽

Epithelial Sodium Channel ◽

Effects of mineralocorticoid receptor antagonist spironolactone on atrial conduction and remodeling in patients with heart failure

Journal of Cardiology ◽

10.1016/j.jjcc.2010.11.006 ◽

2011 ◽

Vol 57 (2) ◽

pp. 208-214 ◽

Cited By ~ 12

Author(s):

Masayasu Kimura ◽

Hiroshi Ogawa ◽

Takatoshi Wakeyama ◽

Akira Takaki ◽

Takahiro Iwami ◽

...

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy

Circulation Heart Failure ◽

10.1161/circheartfailure.113.000792 ◽

2014 ◽

Vol 7 (1) ◽

pp. 51-58 ◽

Cited By ~ 131

Author(s):

Patrick Rossignol ◽

Daniela Dobre ◽

John J.V. McMurray ◽

Karl Swedberg ◽

Henry Krum ◽

...

Keyword(s):

Heart Failure ◽

Renal Function ◽

Receptor Antagonist ◽

Medical Therapy ◽

Prognostic Significance ◽

Optimal Medical Therapy ◽

Worsening Renal Function ◽

Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials

Clinical Research in Cardiology ◽

10.1007/s00392-019-01500-3 ◽

2019 ◽

Vol 109 (2) ◽

pp. 194-204 ◽

Cited By ~ 8

Author(s):

Susan Stienen ◽

Patrick Rossignol ◽

António Barros ◽

Nicolas Girerd ◽

Bertram Pitt ◽

...

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Acute Myocardial Infarction ◽

Receptor Antagonist ◽

Fibrotic Response ◽

Antagonist Therapy ◽

St Elevation ◽

Infarction Heart

Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure

Clinical and Translational Science ◽

10.1111/cts.12702 ◽

2019 ◽

Vol 13 (1) ◽

pp. 195-203

Author(s):

Neven M. Sarhan ◽

Mohamed H. Shahin ◽

Nihal M. El Rouby ◽

Lamia M. El‐Wakeel ◽

Mohamed H. Solayman ◽

...

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Clinical Response ◽

Antagonist Therapy

Implication of Mineralocorticoid Receptor Antagonist Esaxerenone in Patients With Heart Failure With Preserved Ejection Fraction

Circulation Reports ◽

10.1253/circrep.cr-21-0115 ◽

2021 ◽

Author(s):

Teruhiko Imamura ◽

Akira Oshima ◽

Nikhil Narang ◽

Koichiro Kinugawa

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Receptor Antagonist ◽

Preserved Ejection Fraction ◽

Facility variation and predictors of serum potassium monitoring after initiation of a mineralocorticoid receptor antagonist in patients with heart failure

American Heart Journal ◽

10.1016/j.ahj.2015.06.006 ◽

2015 ◽

Vol 170 (3) ◽

pp. 543-549 ◽

Cited By ~ 4

Author(s):

Vishal Chauhan ◽

Sandesh Dev ◽

Michael Pham ◽

Shoutzu Lin ◽

Paul Heidenreich

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Serum Potassium ◽